Daniel Chevallard - Chief Financial Officer, Regulus Therapeutics Inc

As of July 2, 2019


Daniel Chevallard Net Worth

  • Net worth is estimated to be at least $254.14K
  • Owns at least 77,870 units of Regulus Therapeutics Inc stock
  • Sold an estimated value of $20.78K in the last 2 years at Regulus Therapeutics Inc

Daniel Chevallard Trading

  • Largest purchase of shares was 54,945 units , worth over $50K on July 25, 2017
  • Largest sale of shares was 10,000 units , worth over $14.09K on May 16, 2019
  • In total has made about 8 transactions over 2 years
  • Usually trades in May, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Daniel Chevallard Mailing Address

  • Mailing address is C/o Regulus Therapeutics Inc. 10614 Science Center Drive San Diego CA 92121 CA

Regulus Therapeutics Inc Insider Trading

  • The most recent transaction was 76,686 units bought on March 1, 2022 by Denis Drygin worth over $17.64K
  • In the last 10 years, insiders at Regulus Therapeutics Inc sold an estimated value of $79.77M and bought an estimated value of $68.69M
  • The most active traders are Joseph Hagan, President and CEO,  Stelios Papadopoulos, Director,  and Christopher Aker, Sr. VP & General Counsel
  • Insider trading is most common in June, with the busiest year in 2019

Regulus Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1